HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mohammad Bayat Selected Research

Nitrofurazone (Nitrofural)

9/2011Effect of low-level treatment with an 80-Hz pulsed infrared diode laser on mast-cell numbers and degranulation in a rat model of third-degree burn.
10/2010Low-level laser therapy with a pulsed infrared laser accelerates second-degree burn healing in rat: a clinical and microbiologic study.
12/2009Low-level laser therapy using 80-Hz pulsed infrared diode laser accelerates third-degree burn healing in rat.
1/2009Low-level laser therapy with pulsed infrared laser accelerates third-degree burn healing process in rats.
2/2008Effect of low-level laser therapy on mast cells in second-degree burns in rats.
1/2008Effects of low-level laser therapy on mast cell number and degranulation in third-degree burns of rats.
5/2006Effect of low-level helium-neon laser therapy on the healing of third-degree burns in rats.
2/2005Effect of low-level laser therapy on the healing of second-degree burns in rats: a histological and microbiological study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mohammad Bayat Research Topics

Disease

40Wounds and Injuries (Trauma)
09/2022 - 02/2005
13Osteoporosis
10/2020 - 03/2015
12Diabetes Mellitus
09/2022 - 09/2014
9Type 1 Diabetes Mellitus (Autoimmune Diabetes)
09/2022 - 12/2013
9Burns
01/2018 - 02/2005
8Neoplasms (Cancer)
12/2022 - 09/2011
6Inflammation (Inflammations)
05/2021 - 01/2008
5Ulcer
09/2022 - 01/2013
4Diabetic Foot
09/2022 - 01/2013
4Hypoxia (Hypoxemia)
10/2019 - 10/2012
2Type 2 Diabetes Mellitus (MODY)
09/2022 - 01/2020
2Infections
01/2022 - 07/2010
2Congenital Abnormalities (Deformity)
02/2021 - 02/2012
2Ischemia
02/2021 - 10/2012
2Pain (Aches)
10/2018 - 01/2011
1Surgical Wound Infection
01/2022
1Surgical Wound
01/2022
1Glioblastoma (Glioblastoma Multiforme)
12/2021
1Oligospermia (Oligozoospermia)
10/2021
1Azoospermia
10/2021
1Bisphosphonate-Associated Osteonecrosis of the Jaw
05/2021
1Osteonecrosis (Kienbock's Disease)
05/2021
1Phobic Disorders (Phobia)
02/2021
1Myocardial Infarction
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Infarction (Infarctions)
01/2021
1Squamous Cell Carcinoma of Head and Neck
10/2020
1Rheumatoid Arthritis
10/2020
1Hyperplasia
10/2020
1Ankylosing Spondylitis
10/2020

Drug/Important Bio-Agent (IBA)

21phytobacteriomycin (PBM)IBA
09/2022 - 04/2017
10Streptozocin (Streptozotocin)FDA Link
03/2021 - 12/2013
8Nitrofurazone (Nitrofural)FDA Link
09/2011 - 02/2005
6Pharmaceutical PreparationsIBA
12/2022 - 01/2011
6Conditioned Culture MediaIBA
07/2020 - 08/2016
6Pentoxifylline (Trental)FDA LinkGeneric
01/2019 - 09/2012
5CollagenIBA
05/2022 - 06/2006
5CurcuminIBA
03/2021 - 04/2018
5salicylhydroxamic acid (SHAM)IBA
01/2021 - 06/2006
4Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2022 - 05/2018
4Lysergic Acid Diethylamide (LSD)IBA
01/2021 - 10/2010
4HeliumIBA
02/2008 - 02/2005
3Arginine (L-Arginine)FDA Link
02/2022 - 01/2019
3CytokinesIBA
01/2022 - 10/2012
3Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2019 - 09/2017
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2022 - 05/2018
2Anti-Bacterial Agents (Antibiotics)IBA
01/2022 - 07/2010
2Tryptases (Tryptase)IBA
02/2021 - 01/2021
2Transcription Factors (Transcription Factor)IBA
04/2020 - 08/2018
2OsteocalcinIBA
04/2020 - 08/2018
2Metformin (Glucophage)FDA LinkGeneric
03/2020 - 04/2017
2Therapeutic UsesIBA
01/2020 - 01/2014
2Messenger RNA (mRNA)IBA
01/2020 - 10/2012
2DAPIIBA
01/2020 - 08/2019
2Ointments (Pastes)IBA
01/2019 - 01/2008
2GlucocorticoidsIBA
09/2017 - 03/2015
1Oxygen (Dioxygen)IBA
05/2022
1Heterocyclic Compounds (Compounds, Heterocyclic)IBA
02/2022
1Chemokine CXCL12IBA
02/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2022
1Proline (L-Proline)FDA Link
01/2022
1Immunologic Factors (Immunomodulators)IBA
01/2022
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2022
1LipopolysaccharidesIBA
01/2022
1Tobramycin (Nebcin)FDA LinkGeneric
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1Interleukin-10 (Interleukin 10)IBA
01/2022
1Methionine (L-Methionine)FDA Link
01/2022
1ChemokinesIBA
01/2022
1Small Interfering RNA (siRNA)IBA
12/2021
1Class Ia Phosphatidylinositol 3-KinaseIBA
12/2021
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2021
1Busulfan (Busulfex)FDA Link
10/2021
1spirooxindoleIBA
05/2021
1PlasticsIBA
02/2021
1Bevacizumab (Avastin)FDA Link
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1MicroRNAs (MicroRNA)IBA
10/2020
1Bone Morphogenetic Protein 4IBA
10/2020
1beta CateninIBA
10/2020
1Proteins (Proteins, Gene)FDA Link
10/2020
1noggin proteinIBA
10/2020
14-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
10/2020
1OsteoprotegerinIBA
04/2020
1Oxytocin (Pitocin)FDA LinkGeneric
04/2020
1Cadherins (E-Cadherin)IBA
01/2020
1pyrimidineIBA
01/2020
1VimentinIBA
01/2020
1ferric oxide (iron oxide)IBA
06/2019

Therapy/Procedure

53Low-Level Light Therapy (LLLT)
09/2022 - 02/2005
19Lasers (Laser)
06/2019 - 02/2005
6Ovariectomy (Oophorectomy)
10/2020 - 03/2017
5Therapeutics
12/2022 - 01/2020
5Semiconductor Lasers
09/2011 - 01/2009
3General Anesthesia
02/2021 - 05/2011
3Osteotomy
10/2017 - 02/2012
2Rhinoplasty
02/2021 - 02/2012
2Injections
06/2019 - 01/2011
2Orthognathic Surgery
01/2014 - 06/2011
1Debridement
01/2022